GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinium Pharmaceuticals Inc (AMEX:ATNM) » Definitions » Cyclically Adjusted PB Ratio

Actinium Pharmaceuticals (Actinium Pharmaceuticals) Cyclically Adjusted PB Ratio : 1.25 (As of Jun. 10, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinium Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Actinium Pharmaceuticals's current share price is $7.96. Actinium Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $6.39. Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.25.

The historical rank and industry rank for Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

ATNM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.79   Med: 1.36   Max: 2.53
Current: 1.25

During the past years, Actinium Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 2.53. The lowest was 0.79. And the median was 1.36.

ATNM's Cyclically Adjusted PB Ratio is ranked better than
58.09% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs ATNM: 1.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Actinium Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was $1.492. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.39 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Actinium Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinium Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Actinium Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 1.84 1.24 1.96 0.89

Actinium Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 1.33 1.05 0.89 1.23

Competitive Comparison of Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Actinium Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=7.96/6.39
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actinium Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Actinium Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.492/131.7762*131.7762
=1.492

Current CPI (Mar. 2024) = 131.7762.

Actinium Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 4.706 100.560 6.167
201409 2.402 100.428 3.152
201412 -1.925 99.070 -2.561
201503 13.817 99.621 18.277
201506 17.250 100.684 22.577
201509 16.385 100.392 21.507
201512 14.960 99.792 19.755
201603 13.394 100.470 17.567
201606 12.106 101.688 15.688
201609 8.944 101.861 11.571
201612 9.682 101.863 12.525
201703 6.758 102.862 8.658
201706 4.548 103.349 5.799
201709 6.820 104.136 8.630
201712 5.122 104.011 6.489
201803 5.914 105.290 7.402
201806 4.704 106.317 5.830
201809 3.145 106.507 3.891
201812 2.285 105.998 2.841
201903 1.345 107.251 1.653
201906 2.900 108.070 3.536
201909 1.810 108.329 2.202
201912 1.028 108.420 1.249
202003 0.518 108.902 0.627
202006 3.855 108.767 4.670
202009 3.344 109.815 4.013
202012 3.497 109.897 4.193
202103 3.675 111.754 4.333
202106 3.817 114.631 4.388
202109 3.644 115.734 4.149
202112 3.321 117.630 3.720
202203 3.109 121.301 3.377
202206 3.144 125.017 3.314
202209 2.826 125.227 2.974
202212 2.589 125.222 2.725
202303 2.223 127.348 2.300
202306 1.967 128.729 2.014
202309 1.590 129.860 1.613
202312 1.316 129.419 1.340
202403 1.492 131.776 1.492

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Actinium Pharmaceuticals  (AMEX:ATNM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Actinium Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Actinium Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinium Pharmaceuticals (Actinium Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
275 Madison Avenue, 7th Floor, New York, NY, USA, 10016
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
Executives
Sandesh Seth director 300 E 93RD STREET, #20-B, NEW YORK NY 10128
Steve O'loughlin officer: VP, Finance and Corporate Dev. 955 HARTMAN RUN ROAD, MORGANTOWN WV 26507
Dale L. Ludwig officer: Chief Scientific Officer 21 FERNWOOD ROAD, ROCKAWAY NJ 07866-2028
Jeffrey W. Chell director 521 MANDALAY AVENUE #708, CLEARWATER BEACH FL 33767
Ajit Shetty director 643 ZEEDIJK, KNOKKE C9 8300
Anil Kapur officer: Chief Commercial Officer 275 MADISON AVE, SUITE 702, NEW YORK NY 10016
Nitya G. Ray officer: Executive Vice President 14 BAYBURY COURT, EAST HANOVER NJ 07936
Mark Stanley Berger officer: Chief Medical Officer 140 RIVERSIDE DRIVE, APT. 9K, NEW YORK NY 10024
Memorial Sloan-kettering Cancer Center 10 percent owner 1275 YORK AVE., NEW YORK NY 10065
Sergio Traversa director 138 CANTERBURY LN, BLUE BELL PA 19422
C. David Nicholson, director 103 CHILDS ROAD, BASKIN RIDGE NJ 07092
Kaushik J Dave director, officer: President and CEO 4 WATER STREET, EDISON NJ 08820
Richard I Steinhart director 125 ELM STREET, NEW CANAAN CT 06840
Ahlb Holdings, Llc 10 percent owner C/O MSKCC, 1275 YORK AVE., NEW YORK NY 10065
Actinium Holdings, Ltd. 10 percent owner C/O /O STERLING MANAGEMENT, LTD., P.O. BOX HM 29, HAMILTON HM CX D0 00000

Actinium Pharmaceuticals (Actinium Pharmaceuticals) Headlines

From GuruFocus